Chapter title |
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction
|
---|---|
Chapter number | 86 |
Book title |
Heart Failure
|
Published in |
Handbook of experimental pharmacology, January 2016
|
DOI | 10.1007/164_2016_86 |
Pubmed ID | |
Book ISBNs |
978-3-31-959658-7, 978-3-31-959659-4
|
Authors |
Michele Senni, Emilia D’Elia, Michele Emdin, Giuseppe Vergaro |
Abstract |
Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs. In this chapter, we review the role of established biomarkers for heart failure management, according to the main classification of HF phenotypes, based on the measurement of left ventricular ejection fraction, including heart failure with reduced (<40%), preserved (≥50%), and, as recently proposed, mid-range (40-49%) ejection fraction. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Unknown | 49 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 24% |
Other | 4 | 8% |
Researcher | 4 | 8% |
Student > Master | 4 | 8% |
Student > Ph. D. Student | 3 | 6% |
Other | 5 | 10% |
Unknown | 18 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 48% |
Biochemistry, Genetics and Molecular Biology | 4 | 8% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 1 | 2% |
Neuroscience | 1 | 2% |
Other | 0 | 0% |
Unknown | 18 | 36% |